lifestyle.chroniccities.us

Author: LeonaBio, Inc.

LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer

April 23, 2026
Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data

April 21, 2026
LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer

February 3, 2026